Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kim-Heang Ly

Showing results (1-10 of 55) with videos related to

Pageof 6
Sort By:
Presse Medicale (Paris, France : 1983)|September 24, 2019
[Physiopathology of giant cell arteritis: From inflammation to vascular remodeling]Alexis Régent, Kim Heang Ly, Luc Mouthon
Autoimmunity Reviews|May 12, 2010
Pathogenesis of giant cell arteritis: More than just an inflammatory condition?Kim-Heang Ly, Alexis Régent, Mathieu C Tamby, et al.
Ocular Immunology and Inflammation|March 28, 2025
Ischemic Ocular Involvement in Eosinophilic Granulomatosis with Polyangiitis: A Case ReportSébastien Laburthe, Thibaud Loupret, Romain Foré, et al.
Clinical and Experimental Rheumatology|June 5, 2019
The different clinical patterns of giant cell arteritisHubert de Boysson, Eric Liozon, Kim Heang Ly, et al.
Joint Bone Spine|July 30, 2013
Interleukin-1 blockade in refractory giant cell arteritisKim-Heang Ly, Jérôme Stirnemann, Eric Liozon, et al.
The Journal of Rheumatology|May 3, 2016
Risk Factors for Permanent Visual Loss in Biopsy-proven Giant Cell Arteritis: A Study of 339 PatientsEric Liozon, François Dalmay, Fabrice Lalloue, et al.
Clinical Rheumatology|August 1, 2018
Giant cell arteritis presenting as isolated inflammatory response and/or fever of unknown origin: a case-control studyHubert de Boysson, Eric Liozon, Kim Heang Ly, et al.
Rheumatology International|April 6, 2023
New-onset giant cell arteritis with lower ESR and CRP level carries a similar ischemic risk to other forms of the disease but has an excellent late prognosis: a case-control studyEric Liozon, Simon Parreau, Stéphanie Dumonteil, et al.
Journal of Clinical Medicine|December 23, 2022
Immune-Mediated Diseases Following COVID-19 Vaccination: Report of a Teaching Hospital-Based Case-SeriesEric Liozon, Matthieu Filloux, Simon Parreau, et al.
The Journal of Rheumatology|March 17, 2018
Development of Giant Cell Arteritis after Treating Polymyalgia or Peripheral Arthritis: A Retrospective Case-control StudyEric Liozon, Hubert de Boysson, François Dalmay, et al.
Pageof 6

Showing results (1-10 of 55) with videos related to

Sort By:
Pageof 6
Presse Medicale (Paris, France : 1983)|September 24, 2019
[Physiopathology of giant cell arteritis: From inflammation to vascular remodeling]Alexis Régent, Kim Heang Ly, Luc Mouthon
Autoimmunity Reviews|May 12, 2010
Pathogenesis of giant cell arteritis: More than just an inflammatory condition?Kim-Heang Ly, Alexis Régent, Mathieu C Tamby, et al.
Ocular Immunology and Inflammation|March 28, 2025
Ischemic Ocular Involvement in Eosinophilic Granulomatosis with Polyangiitis: A Case ReportSébastien Laburthe, Thibaud Loupret, Romain Foré, et al.
Clinical and Experimental Rheumatology|June 5, 2019
The different clinical patterns of giant cell arteritisHubert de Boysson, Eric Liozon, Kim Heang Ly, et al.
Joint Bone Spine|July 30, 2013
Interleukin-1 blockade in refractory giant cell arteritisKim-Heang Ly, Jérôme Stirnemann, Eric Liozon, et al.
The Journal of Rheumatology|May 3, 2016
Risk Factors for Permanent Visual Loss in Biopsy-proven Giant Cell Arteritis: A Study of 339 PatientsEric Liozon, François Dalmay, Fabrice Lalloue, et al.
Clinical Rheumatology|August 1, 2018
Giant cell arteritis presenting as isolated inflammatory response and/or fever of unknown origin: a case-control studyHubert de Boysson, Eric Liozon, Kim Heang Ly, et al.
Rheumatology International|April 6, 2023
New-onset giant cell arteritis with lower ESR and CRP level carries a similar ischemic risk to other forms of the disease but has an excellent late prognosis: a case-control studyEric Liozon, Simon Parreau, Stéphanie Dumonteil, et al.
Journal of Clinical Medicine|December 23, 2022
Immune-Mediated Diseases Following COVID-19 Vaccination: Report of a Teaching Hospital-Based Case-SeriesEric Liozon, Matthieu Filloux, Simon Parreau, et al.
The Journal of Rheumatology|March 17, 2018
Development of Giant Cell Arteritis after Treating Polymyalgia or Peripheral Arthritis: A Retrospective Case-control StudyEric Liozon, Hubert de Boysson, François Dalmay, et al.
Pageof 6